Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer

Breast Cancer Research and Treatment

Volumn 42, Issue 1, 1997, Pages 7-14

  Taylor, Charles W ^a,b   Dalton, William S ^a   Mosley, Kurt ^a   Dorr, Robert T ^a   Salmon, Sydney E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Chemosensitizers; Drug resistance; Metastatic breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; QUININE; VERAPAMIL; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CUSHINGOID SYNDROME; DISEASE COURSE; DRUG EFFICACY; DRUG POTENTIATION; EDEMA; FATIGUE; FEMALE; GRANULOCYTOPENIA; HUMAN; HUMAN TISSUE; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NEUROPATHY; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; STOMATITIS; TACHYCARDIA; THROMBOCYTOPENIA; TINNITUS; VERTIGO; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; QUININE; TREATMENT OUTCOME; TUMOR STEM CELL ASSAY; VERAPAMIL; VINCRISTINE;

EID: 0031033486     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005716214718     Document Type: Article

References (23)

1. Henderson IC: Chemotherapy for metastatic disease. In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds) Breast Diseases. J.B. Lippincott Co, Philadelphia, 1991, p 604-665
2. Gerlach JH, Kartner N, Bell DR, Ling V: Multidrug resistance. Cancer Surveys 5: 25-46, 1986
3. Pastan I, Gottesman M: Multiple-drug resistance in human cancer. N Engl J Med 316: 1388-1393, 1987
4. Merkel DE, Fuqua SAW, Tandon AK, Hill SM, Buzdar AU, McGuire WL: Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol 7: 1129-1136, 1989
5. Schneider J, Bak M, Efferth T, Kaufmann M, Mattern J, Volm M: P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60: 815-818, 1989
6. Ro J, Sahin A, Ro JY, Fritsche H, Hortobagyi G, Blick M: Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 21: 787-791, 1990
7. Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T, Kaye SB: P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer 62: 758-761, 1990
8. Sanfilippo O, Ronchi E, De Marco C, Di Fronzo G, Silvestrini R: Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer 27: 155-158, 1991
9. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F, Plagne R, Chassagne J: Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 83: 111-116, 1991
10. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ, Trent JM: Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 63: 923-929, 1991
11. Salmon SE, Grogan TM, Miller T, Scheper R, Dalton WS: Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 81: 696-701, 1989
12. Lehnert M, Dalton WS, Roc D, Emerson S, Salmon SE: Synergistic inhibition by verapamil and quinine of p-glycoprotein-mediated multidrug resistance in a human myeloma cell line model. Blood 2: 348-354, 1991
13. Mickisch GH, Merlino GT, Galski H, Gottesman MM, Pastan I: Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc Natl Acad Sci USA 88: 547-551, 1991
14. Salmon SE, Hamburger AW, Soehnlen BJ, Durie BGM, Alberts DS, Moon TE: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321-1327, 1978
15. Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnen M, Roe DJ, Miller TP: Multidrug-resistant myeloma - Laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78: 44-50, 1991
16. Kressner BE, Morion RR, Martens AH, Salmon SE, Von Hoff DD, Soehnlen B: Use of an image analysis system to count colonies and stem cell assays of human tumors. Progress in Clinical and Biological Research 179-193, 1980
17. Merkel DE, Fuqua SAW, McGuire WL: P-glycoprotein in breast cancer. Cancer Treat Res 48: 97-105, 1989
18. Merkel DE, Fuqua SA, Hill SM, Mcguire WL: P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimens. Prog Clin Biol Res 276:61-73, 1988
19. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP, Salmon SE: Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7: 415-424, 1989
20. Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE: P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high dose verapamil. J Clin Oncol 9(1): 17-24, 1991
21. Ries F, Dicato M: Treatment of advanced and refractory breast cancer with doxorubicin, vincristine and continuous infusion of verapamil. A phase I-II clinical trial. Medical Oncology & Tumor Pharmacotherapy 8: 39-43, 1991
22. Mross K, Bonn C, Edler L, Jonat W, Queisser W, Heidemann E, Goebel M, Hossfeld DK: Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Annals of Oncology 4: 45-50, 1993
23. Wishart GC, Bissett D, Paul J, Jodrell D, Harriett A, Habeshaw T, Kerr DJ, Macham MA, Soukop M, Leonard RCF, Knepil J, Kaye SB: Quinidine as a resistance modulator of epirubicin in advanced breast cancer: Mature results of a placebo-controlled randomized trial. J Clin Oncol 12:1771-1777, 1994